QUOTED. March 1, 2018. Joerg Kruetten.
Check out what Simon-Kucher & Partners consultant Joerg Kruetten had to say about the opportunities and pitfalls of new medtech business models based on his firm's "Medtech Barometer" survey.
You may also be interested in...
European medtech companies are changing the way they do business. These new business models are enabling them to overcome market challenges and will allow them to keep growing their business if successfully implemented, an industry survey by Simon-Kucher & Partners has revealed.
The Chinese government's plan to reduce tariffs it imposed on a slew of US exports is expected to have minimal impact on the overall medtech industry. See what Ralph Ives, AdvaMed's executive VP for global strategy, said about it here.